EverSource Wealth Advisors
CAMP icon

EverSource Wealth Advisors’s CAMP4 Therapeutics CAMP Stock Holding History

EverSource Wealth Advisors’s Portfolio CAMP Stock Details CAMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4 Buy
+1
New +$4 ﹤0.01% 4535
2025
Q3 		– Sell
-3
Closed -$4 – 4343
2025
Q2 		$4 Sell
3
-13
-81% -$26 ﹤0.01% 4241
2025
Q1 		$64 Buy
+16
New +$77 ﹤0.01% 3874

Other funds holding CAMP

Vivo Capital
Vivo Capital Palo Alto, California $909M AUM 385.65% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Stonepine Capital Management
Stonepine Capital Management Bend, Oregon $159M AUM 62.27% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

EverSource Wealth Advisors's CAMP Position: Q3 2026 in Review

EverSource Wealth Advisors opened a new position in CAMP4 Therapeutics (CAMP) in Q3 2026: 1 share worth $4. The stake represents ﹤0.01% of the portfolio and ranks #4535 among its holdings. This is a return to the name: EverSource Wealth Advisors previously reported a position in CAMP as recently as Q2 2025.

EverSource Wealth Advisors first reported a position in CAMP in Q1 2025 and has held it in 3 quarters since. The position peaked at $64 in Q1 2025. 39 funds tracked by Wall St. Rank hold CAMP as of Q3 2026.

  • EverSource Wealth Advisors held 1 share of CAMP4 Therapeutics worth $4 as of Q3 2026.
  • CAMP4 Therapeutics was a new EverSource Wealth Advisors position in Q3 2026.
  • CAMP4 Therapeutics made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q3 2026, its #4535 holding.
  • EverSource Wealth Advisors first reported a position in CAMP4 Therapeutics in Q1 2025 and has held it in 3 quarters since.
  • EverSource Wealth Advisors's CAMP4 Therapeutics position peaked at $64 in Q1 2025.
  • 39 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q3 2026.

Based on EverSource Wealth Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.